Clinical relevance of collagen protein degradation markers C3 M and C4 M in the serum of breast cancer patients treated with neoadjuvant therapy in the GeparQuinto trial - Banys-Paluchowski, M; Loibl, S; Witzel, I; Mundhenke, C; Lederer, B; Solbach, C; Karn, T; Marmé, F; Nekljudova, V; Schem, C; Stickeler, E; Untch, M; Müller, V (Senologie - Zeitschrift für Mammadiagnostik und -therapie, 2019)